What is more, Wei et al. showed by experimentation that the highly expressed lncRNA-SNHG1 could directly target hsa-miR-101-3p (which form the basis of the three ceRNA axes we predicted for HCC) to up-regulate ROCK2, and thus lowering the sensitivity of NSCLC cells to cisplatin in non-small cell lung cancer tissues [62]. This evidence concerns the gene ROCK2 and hepatocellular carcinoma.